Durvalumab extends survival in stage III non-small cell lung CA 10-30-2018 mediabest Health Problems (HealthDay)—Durvalumab results in significantly longer overall survival than placebo among Read more
Adjuvant pembrolizumab beneficial in stage III melanoma 04-16-2018 James Health Problems (HealthDay)—Pembrolizumab is associated with significantly longer recurrence-free survival than placebo Read more